Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

ConditionBone Lesion
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorCentral Hospital, Nancy, France

About this trial

The hypothesis of the study is that non-invasive Single photon emission computed tomography (SPECT-CT) bone scintigraphy makes it possible to better characterize solitary bone lesions, in particular the exclusion of their malignancy in order to avoid unnecessary biopsy and possible complications for the patient.

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

Having read and understood the information document.

Affiliated to a social security scheme.

Patient with an indeterminate solitary bone lesion on conventional imaging, for which an indication for biopsy +/- excision is planned.

Disqualifiers

Pregnant woman or woman of childbearing age and without contraceptive means or nursing mother.

Unstable medical condition and/or inability to remain still during recordings.

Known allergy to one of the components of the radiopharmaceutical technetium-99m-Technescan HDP (product required to perform the bone scan).

Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.

Trial design

Treatments tested in this trial

  • Bone scan

Treatment groups

68 Participants
are divided into 1 treatment group